NeoGenomics, Inc. total revenue, net income and dynamics of changes in US dollar today
NeoGenomics, Inc. current income and income for the latest reporting periods. Net revenue NeoGenomics, Inc. is now 115 533 000 $. Information about net revenue is taken from open sources. Net income, revenue and dynamics - the main financial indicators of NeoGenomics, Inc.. Graph of the financial report of NeoGenomics, Inc.. All information on NeoGenomics, Inc. total revenue on this chart is created in the form of yellow bars. The value of NeoGenomics, Inc. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
115 533 000 $
+20.88 % ↑
-22 114 000 $
-
31/12/2020
125 997 000 $
+64.76 % ↑
15 417 000 $
+4 267.420 % ↑
30/09/2020
125 444 000 $
+19.84 % ↑
2 557 000 $
+19.32 % ↑
30/06/2020
86 977 000 $
-14.488 % ↓
-6 824 000 $
-442.742 % ↓
30/09/2019
104 672 000 $
-
2 143 000 $
-
30/06/2019
101 713 000 $
-
1 991 000 $
-
31/03/2019
95 577 000 $
-
-2 424 000 $
-
31/12/2018
76 475 000 $
-
353 000 $
-
30/09/2018
69 096 000 $
-
2 023 000 $
-
30/06/2018
67 746 000 $
-
-380 000 $
-
31/03/2018
63 423 000 $
-
644 000 $
-
31/12/2017
67 793 000 $
-
4 951 000 $
-
30/09/2017
63 052 000 $
-
-5 100 000 $
-
30/06/2017
66 090 000 $
-
-43 000 $
-
Show:
to
NeoGenomics, Inc. financial report charts
The dates of the latest financial statements of NeoGenomics, Inc.: 30/06/2017, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of NeoGenomics, Inc. is 31/03/2021. Gross profit NeoGenomics, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit NeoGenomics, Inc. is 46 835 000 $
NeoGenomics, Inc. quarterly report dates
Cost of revenue NeoGenomics, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue NeoGenomics, Inc. is 68 698 000 $ Total revenue NeoGenomics, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue NeoGenomics, Inc. is 115 533 000 $ Operating income NeoGenomics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income NeoGenomics, Inc. is -7 772 000 $
Net income NeoGenomics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income NeoGenomics, Inc. is -22 114 000 $ Current assets NeoGenomics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets NeoGenomics, Inc. is 942 732 000 $ Total assets NeoGenomics, Inc. refers to the total amount of assets owned by a person or entity. Total assets NeoGenomics, Inc. is 1 494 413 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
46 835 000 $
57 926 000 $
54 065 000 $
28 006 000 $
50 832 000 $
48 966 000 $
47 115 000 $
37 110 000 $
32 321 000 $
30 530 000 $
27 303 000 $
33 132 000 $
28 810 000 $
31 178 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
68 698 000 $
68 071 000 $
71 379 000 $
58 971 000 $
53 840 000 $
52 747 000 $
48 462 000 $
39 365 000 $
36 775 000 $
37 216 000 $
36 120 000 $
34 661 000 $
34 242 000 $
34 912 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
115 533 000 $
125 997 000 $
125 444 000 $
86 977 000 $
104 672 000 $
101 713 000 $
95 577 000 $
76 475 000 $
69 096 000 $
67 746 000 $
63 423 000 $
67 793 000 $
63 052 000 $
66 090 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
104 672 000 $
101 713 000 $
95 577 000 $
76 475 000 $
69 096 000 $
67 746 000 $
63 423 000 $
67 793 000 $
63 052 000 $
66 090 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-7 772 000 $
5 760 000 $
5 115 000 $
-18 797 000 $
3 993 000 $
4 990 000 $
3 814 000 $
5 146 000 $
4 590 000 $
2 616 000 $
2 505 000 $
4 487 000 $
-2 304 000 $
1 314 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-22 114 000 $
15 417 000 $
2 557 000 $
-6 824 000 $
2 143 000 $
1 991 000 $
-2 424 000 $
353 000 $
2 023 000 $
-380 000 $
644 000 $
4 951 000 $
-5 100 000 $
-43 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
2 456 000 $
2 100 000 $
1 964 000 $
2 105 000 $
2 611 000 $
2 587 000 $
1 209 000 $
526 000 $
446 000 $
1 073 000 $
956 000 $
556 000 $
1 270 000 $
947 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
123 305 000 $
120 237 000 $
120 329 000 $
105 774 000 $
100 679 000 $
96 723 000 $
91 763 000 $
71 329 000 $
64 506 000 $
65 130 000 $
24 798 000 $
28 645 000 $
31 114 000 $
29 864 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
942 732 000 $
448 730 000 $
422 375 000 $
419 000 000 $
292 001 000 $
276 345 000 $
115 945 000 $
103 668 000 $
194 270 000 $
83 259 000 $
87 771 000 $
84 963 000 $
85 747 000 $
83 357 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 494 413 000 $
988 331 000 $
959 428 000 $
945 485 000 $
711 155 000 $
696 667 000 $
533 343 000 $
505 015 000 $
455 139 000 $
345 783 000 $
349 272 000 $
343 340 000 $
343 895 000 $
339 880 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
611 970 000 $
228 713 000 $
233 233 000 $
295 281 000 $
178 891 000 $
167 436 000 $
13 195 000 $
9 811 000 $
118 440 000 $
9 435 000 $
15 173 000 $
12 821 000 $
12 211 000 $
10 932 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
68 907 000 $
59 162 000 $
72 703 000 $
60 925 000 $
47 055 000 $
47 974 000 $
10 207 000 $
8 989 000 $
8 486 000 $
8 642 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
15 173 000 $
12 821 000 $
12 211 000 $
10 932 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
214 148 000 $
206 933 000 $
209 495 000 $
184 572 000 $
151 580 000 $
181 574 000 $
101 044 000 $
105 424 000 $
105 061 000 $
109 309 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
30.11 %
29.70 %
39.28 %
36.55 %
33.30 %
52.51 %
28.93 %
30.71 %
30.55 %
32.16 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
843 714 000 $
694 294 000 $
666 363 000 $
654 229 000 $
497 007 000 $
489 734 000 $
323 848 000 $
320 443 000 $
303 559 000 $
164 209 000 $
172 545 000 $
172 918 000 $
169 533 000 $
168 898 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
18 634 000 $
-4 721 000 $
6 097 000 $
15 453 000 $
8 381 000 $
6 640 000 $
14 312 000 $
5 759 000 $
7 436 000 $
6 528 000 $
Last revenue report of NeoGenomics, Inc. was 31/03/2021. According to last financial report total revenue in NeoGenomics, Inc. was 115 533 000 US dollar and changed by +20.88% since last year. Net income in NeoGenomics, Inc. was -22 114 000 $ in last quartal, net income changes to +4 267.420%.
Current cash NeoGenomics, Inc. - the sum of all of the cash a company has on the date of report. Current cash NeoGenomics, Inc. is 611 970 000 $
NeoGenomics, Inc. stocks data
NEO stock price
NeoGenomics, Inc. stock price today, NEO stock quote.
